Chelation trial for heart disease under fire

Health 9 July 2008

IT’S a trial of a controversial alternative therapy for heart disease, and it involves some physicians with criminal records and others who have been disciplined by state medical boards. So why is the world’s leading biomedical research agency backing it?

That’s the question being asked by critics of a $30 million study funded by the US National Institutes of Health (NIH), who want the trial stopped.

The row involves chelation therapy, generally used to remove toxic heavy metals from the body. Some alternative practitioners claim that chelation can also dissolve the plaques that can form in arteries and increase …

Continue reading

Subscribe for unlimited digital access

Subscribe now for unlimited access


Paid annually by Credit Card

Inclusive of applicable taxes (VAT)